Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Assets (2020 - 2025)

Biofrontera (BFRI) has 6 years of Assets data on record, last reported at $15.4 million in Q3 2025.

  • For Q3 2025, Assets fell 16.75% year-over-year to $15.4 million; the TTM value through Sep 2025 reached $15.4 million, down 16.75%, while the annual FY2024 figure was $22.1 million, 20.88% down from the prior year.
  • Assets reached $15.4 million in Q3 2025 per BFRI's latest filing, down from $20.1 million in the prior quarter.
  • Across five years, Assets topped out at $55.1 million in Q3 2022 and bottomed at $15.4 million in Q3 2021.
  • Average Assets over 5 years is $32.5 million, with a median of $26.3 million recorded in 2023.
  • Peak YoY movement for Assets: skyrocketed 258.6% in 2022, then tumbled 45.71% in 2024.
  • A 5-year view of Assets shows it stood at $53.2 million in 2021, then fell by 4.39% to $50.9 million in 2022, then plummeted by 45.11% to $27.9 million in 2023, then decreased by 20.88% to $22.1 million in 2024, then crashed by 30.25% to $15.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets were $15.4 million in Q3 2025, $20.1 million in Q2 2025, and $16.6 million in Q1 2025.